Leaflet COPAXONE 20mg lyophilisate and solvent for solution for injection

Product code:
W44043002
Quantity:
28
Indicated for:
multiple sclerosis
Route of administration:
injectable
Substance:
glatiramer acetate (immunomodulator)
ATC
L03AX13 — Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Other immunostimulants

Precautions:

Avoid live vaccines

Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Immunosuppression / infection risk

Immunosuppression / infection risk

This medicine may increase the risk of infections.

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Glatiramer acetate is a medication used for the treatment of relapsing-remitting multiple sclerosis. It works by modulating the immune response, reducing inflammation, and preventing damage to myelin, the protective layer of nerves.

The medication is administered via subcutaneous injection, usually daily or several times a week, depending on the dosage. Glatiramer acetate has shown efficacy in reducing relapse frequency and slowing disease progression.

Common side effects include injection site reactions, flushing, and palpitations. It is important for patients to be properly trained in injection administration and monitored for potential side effects.

Glatiramer acetate is a well-established therapeutic option for patients with multiple sclerosis, helping to improve their quality of life.

General data about COPAXONE 20mg

Substance:
glatiramer acetate
Date of latest medicines list:
01-07-2013
Product code:
W44043002
Concentration:
20mg
Pharmaceutical form:
lyophilisate and solvent for solution for injection
Quantity:
28
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Concentrations available for glatiramer acetate

  • 20mg
  • 20mg/ml
  • 40mg/ml